Inmune Bio, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Inmune Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Inmune Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$12.1M, a 41.2% decline year-over-year.
  • Inmune Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$41.3M, a 50.4% decline year-over-year.
  • Inmune Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$30M, a 9.92% decline from 2022.
  • Inmune Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$27.3M, a 10% increase from 2021.
  • Inmune Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$30.3M, a 151% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$30M -$2.71M -9.92% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$27.3M +$3.04M +10% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$30.3M -$18.2M -151% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$12.1M -$4.42M -57.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 -$7.68M +$4.76M +38.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 -$12.4M -$11.6M -1396% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 -$831K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.